VAMP8 and nasopharyngeal carcinoma: Our findings open venues to future studies to explore VAMP8/DHX9/p65 axis as biomarkers and therapeutic targets in NPC, with implications for understanding the broader genetic and molecular mechanisms of NPC pathogenesis.